FR2059554B1 - - Google Patents

Info

Publication number
FR2059554B1
FR2059554B1 FR707027250A FR7027250A FR2059554B1 FR 2059554 B1 FR2059554 B1 FR 2059554B1 FR 707027250 A FR707027250 A FR 707027250A FR 7027250 A FR7027250 A FR 7027250A FR 2059554 B1 FR2059554 B1 FR 2059554B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR707027250A
Other versions
FR2059554A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2059554A1 publication Critical patent/FR2059554A1/fr
Application granted granted Critical
Publication of FR2059554B1 publication Critical patent/FR2059554B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
FR707027250A 1969-07-24 1970-07-23 Expired FR2059554B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1938218A DE1938218C3 (de) 1969-07-24 1969-07-24 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2059554A1 FR2059554A1 (fr) 1971-06-04
FR2059554B1 true FR2059554B1 (fr) 1974-06-14

Family

ID=5741103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR707027250A Expired FR2059554B1 (fr) 1969-07-24 1970-07-23

Country Status (18)

Country Link
US (1) US3681405A (fr)
JP (1) JPS4815290B1 (fr)
AT (1) AT300217B (fr)
BE (1) BE753874A (fr)
CH (1) CH557339A (fr)
CS (1) CS161757B2 (fr)
DE (1) DE1938218C3 (fr)
DK (1) DK122454B (fr)
ES (1) ES381790A1 (fr)
FI (1) FI46844C (fr)
FR (1) FR2059554B1 (fr)
GB (1) GB1317194A (fr)
IE (1) IE34401B1 (fr)
IL (1) IL34976A (fr)
NL (1) NL7010876A (fr)
PL (1) PL79781B1 (fr)
SE (1) SE355578B (fr)
ZA (1) ZA704574B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2725008C (fr) 2008-05-28 2017-09-05 Validus Biopharma, Inc. Modulateurs steroidiens non hormonaux de nf-.kappa.b pour le traitement d'une maladie
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
WO2017004205A1 (fr) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. Modulateurs stéroïdiens non hormonaux de nf-κb pour le traitement de maladies
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
US3025312A (en) * 1959-07-14 1962-03-13 Olin Mathieson 9alpha, 11beta-dichloro pregnanes
US3038898A (en) * 1960-11-10 1962-06-12 Syntex Sa 6-fluoromethyl-9alpha, 11beta-dichlorocortical hormones

Also Published As

Publication number Publication date
GB1317194A (en) 1973-05-16
US3681405A (en) 1972-08-01
FI46844C (fi) 1973-07-10
CH557339A (de) 1974-12-31
AT300217B (de) 1972-07-25
CS161757B2 (fr) 1975-06-10
BE753874A (fr) 1971-01-25
DE1938218C3 (de) 1978-10-19
IL34976A0 (en) 1970-09-17
SE355578B (fr) 1973-04-30
DE1938218B2 (de) 1978-01-26
DK122454B (da) 1972-03-06
FR2059554A1 (fr) 1971-06-04
IL34976A (en) 1973-06-29
IE34401L (en) 1971-01-24
DE1938218A1 (de) 1971-02-04
FI46844B (fr) 1973-04-02
ES381790A1 (es) 1972-12-01
IE34401B1 (en) 1975-04-30
PL79781B1 (fr) 1975-06-30
ZA704574B (en) 1971-03-31
NL7010876A (fr) 1971-01-26
JPS4815290B1 (fr) 1973-05-14

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU465452B2 (fr)
AU450150B2 (fr)
FR2059554B1 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU427401B2 (fr)
AU414607B2 (fr)
AU417208B2 (fr)
AU442535B2 (fr)
AU442463B2 (fr)
AU442554B2 (fr)
AT308690B (fr)
AU470661B1 (fr)
AU410358B2 (fr)
AU442538B2 (fr)
AU425297B2 (fr)
AU442380B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU5228269A (fr)
AR203167Q (fr)
AU1036070A (fr)
AU480213A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse